Addition of multimodal therapy to standard management of steady state sickle cell disease.
Okpala I, Ezenwosu O, Ikefuna A, Duru A, Chukwu B, Madu A, Nwagha T, Ocheni S, Ibegbulam O, Emodi I, Anike U, Nonyelu C, Anigbo C, Agu K, Ajuba I, Chukwura A, Ugwu O, Ololo U.
Okpala I, et al. Among authors: nwagha t.
ISRN Hematol. 2013 Dec 9;2013:236374. doi: 10.1155/2013/236374. eCollection 2013.
ISRN Hematol. 2013.
PMID: 24386573
Free PMC article.